Binh Thai - Thailand

“COVID test kits will need to undergo in-country validation as part of the Class 4 Licensing process in Thailand.”

Binh Thai
General Manager
Asia Actual Thailand

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sources and Links

Thai Requirements for COVID Test Kits

Published on: May 19th, 2021

Similar to other markets in the region, manufacturers of COVID test kits will need to undergo in-country validation as part of the Class 4 Licensing process in Thailand. Like all other medical devices under the new Thai rules, the Thai FDA may take approvals in other countries into account but does not currently have an expedited review route for COVID test products approved in other markets including reference countries. Depending on the type of test, validation fees will vary from 65,000 baht (US$2,200) up to 143,200 baht (US$4,800) and could take 1-4 months to complete. Once validation testing has been completed, manufacturers can then submit their License application through their local office or license holder which incurs a US$1,775)

Validation Requirements

Requirements vary depending on the type of test with sample requirements varying from 100-200 samples. Antigen tests will even require a local clinical trial. Along with lab fees, there will also be a 3,200 baht TFDA application fee applicable to all products.

  • Real Time RT-PCR tests will require 100 samples with lab fees not to exceed 100,000 baht (US$3,000). It is estimated that validation will require 30 working days plus the technology assessment (time required varies).
  • Antibody tests will require 200 samples with lab fees not to 140,000 baht (US$4,600). Validation timeline is currently about 75 days but does depend on the number of products in the queue.
  • Antigen tests will need to work with a local hospital to coordinate a clinical trial before being approved for sale in Thailand. The size, costs, and timelines will depend on the agreement made with the partner hospital plus 30 days for the TFDA’s review.

The TFDA has released a few guidance documents to help manufacturers better understand the process but are currently only available in Thai.

Come Grow With Us

Contact Asia Actual if you’d like to learn more about the regulatory process in Thailand or other markets in the region.

Asia Actual is a regulatory consulting company specializing in helping manufacturers grow their sales through independent license holding, direct fulfillment, and a variety of sales channel support services.

Blog Posts

The Philippines FDA Releases List of VAT Exempt Therapeutic Products

On September 14th, the Philippines FDA released FDA Advisory No.2021-2293, outlining the list of VAT-Exempt Products pursuant to Republic Act No. 11534, otherwise known as the “Corporate Recovery and Tax Incentives for Enterprises (CREATE) Act."

Asia Actual Launches Online Medical Device Approval Search Service

Asia Actual is excited to launch R.O.S.E., the Registration Optimized Search Engine. The goal of R.O.S.E. is to provide centralized access to medical device registration data in Asian markets. 

Philippines Releases New Guidance on Class A Medical Devices

the FDA has released a list of Class A 1,242 product categories in Circular 2021-017 on August 16, 2021. Medical device manufacturers of Class A products specified in Annex A or under the ASEAN MDD, must obtain a Certificate of Medical Device Notification (CMDN).